Capecitabine 3-O-BDR Impurity (USP)
Product Description
CAT No.
ALN-C003010
CAS No.
1262133-64-1
Mol. F.
C20H30FN3O9
Mol. Wt.
475.5
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : [1-[5-Deoxy-3-O-(5-deoxy-β-d-ribofuranosyl)-β-d-ribofuranosyl]-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]-carbamic acid pentyl ester (as per USP)
Smiles : O=C(OCCCCC)NC(C(F)=CN1[C@H]2[C@@H]([C@@H]([C@@H](C)O2)O[C@H]3[C@@H]([C@@H]([C@@H](C)O3)O)O)O)=NC1=O
Inchi : InChI=1S/C20H30FN3O9/c1-4-5-6-7-30-20(29)23-16-11(21)8-24(19(28)22-16)17-15(13(26)10(3)31-17)33-18-14(27)12(25)9(2)32-18/h8-10,12-15,17-18,25-27H,4-7H2,1-3H3,(H,22,23,28,29)/t9-,10-,12-,13-,14-,15-,17-,18+/m1/s1
Technical Data
Reference
Design of experiments (DoE) - based enhanced quality by design approach to hydrolytic degradation kinetic study of capecitabine by eco-friendly stability indicating UV-visible spectrophotometry
By Prajapati, Pintu; Patel, Radhika; Patel, Dilan; Shah, ShaileshnFrom American Journal of PharmTech Research (2020), 10(6), 115-133
Validated stability indicating HPLC method for estimation of capecitabine
By Lalitha, K. V.; Raveendra Reddy, J.; Devanna, N. – From International Journal of Pharmaceutical Sciences and Research (2020), 11(11), 5651-5658
RP-HPLC method development and validation for the simultaneous estimation of Irinotecan hydrochloride and Capecitabine in Active Pharmaceutical Ingredients (APIs)
By Vijaya Jyothi, M.; Bhargav, E.; Keerthana, B.; Varalakshmi, Devi K. – From International Journal of Research in Pharmaceutical Sciences (Madurai, India) (2018), 9(1), 63-67
RFQ